POSTER SESSION VI
Wednesday, March 5, 2008   —  1:00 PM - 4:00 PM
Convention Center Exhibit Hall A


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


HEMATOPATHOLOGY



Poster#Title and AuthorsItinerary
Planner
144 Nutlin-3, an MDM2 Antagonist, Induces p53-Dependent Cell Cycle Arrest and Apoptosis in t(14;18)-Associated B-Cell Lymphoma (1154)
E Drakos, GZ Rassidakis, J Li, RJ Ford, JL Medeiros - The University of Texas, MD Anderson Cancer Center, Houston, TX 		Add
145 Mixed Lineage Kinase-3 Expression in Follicular Lymphoma (1120)
S Almiski, N Razumilava, M Kurrer, E Levi - Harper University Hospital, Wayne State University, Detroit; Cantonal Hospital Aarau, Aarau, Switzerland; John D. Dingell VAMC, Detroit 		Add
146 Pediatric Marginal Zone B-Cell Lymphomas; Analysis of Histopathology, Immunophenotype and Genetic Aberrations (1240)
KA Rizzo, B Streubel, A Chott, S Pittaluga, M Raffeld, ES Jaffe - National Institutes of Health, Bethesda, MD; Vienna General Hospital, Vienna, Austria 		Add
147 Comparative Analysis of Immunoglobulin VH Gene Sequences in Splenic Marginal Zone Lymphomas and Waldenstrom Macroglobulinemia with Bone Marrow Infiltration (1151)
A de Mascarel, N Gachard, M Parrens, B Petit, K Bouabdallah, N Milpied, JP Merlio, I Soubeyran, J Feuillard - University Hospital of Bordeaux, Bordeaux, France; University Hospital of Limoges, Limoges, France; Institut Bergoni[eacute], Bordeaux, France 		Add
148 Utility of CD5 and CD43 Fluorescence Intensity in Distinguishing Splenic Marginal Zone Lymphoma from Chronic Lymphocytic Leukemia (1229)
DM Pierson, LJ Medeiros, LV Abruzzo, JL Jorgensen - UT MD Anderson Cancer Center, Houston, TX 		Add
149 B-Cell Lymphomas with CDK6 Gene Translocations Represent a Distinct Clinicopathological Entity (1134)
D Chen, ME Law, A Dogan, ED Remstein - Mayo Clinic, Rochester, MN 		Add
150 Flow Cytometric Analysis of CD36 (Thrombospondin 1 Receptor) in Low-Grade B-Cell Non-Hodgkin's Lymphomas: Common Expression in Splenic Marginal Zone B-Cell Lymphoma (1225)
GP Paner, G Venkataraman, M Velankar, B Bonilla, E Hsi, S Alkan - Loyola University Medical Center, Maywood, IL; The Cleveland Clinic Foundation, Cleveland, OH 		Add
151 Angiogenesis, Mast Cells, and Fibrosis in Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia in Bone Marrow: Role of the Nuclear Factor-kappa B Pathway (1187)
MR Johnson, LJ Medeiros, CE Bueso-Ramos - University of Texas M.D. Anderson Cancer Center, Houston, TX 		Add
152 Ocular Adnexal Lymphomas: Outcome in 181 Patients (1160)
JA Ferry, CY Fung, RP Hasserjian, MJ Lucarelli, NL Harris - Massachusetts General Hospital, Boston, MA; University of Wisconsin-Madison, Madison, WI 		Add
153 Marginal Zone Lymphoma - The Great Mimic: A Pathologic Review of 65 Cases Reclassified by Current WHO Criteria (1268)
LHC Tan - Singapore General Hospital, Singapore, Singapore 		Add
154 CD5-Positive Marginal Zone Lymphomas Do Not Significantly Differ from CD5-Negative Cases (1133)
A Chadburn, H Ghaffar, Y Liu, T Zhang, P Chadwick, W Tam - Weill Cornell Medical College, New York, NY 		Add
155 Is CD13 Expression a Marker of Lymphoplasmacytic Lymphoma? (1219)
CG Morosan, RW Allan - University of Florida, Gainesville, FL 		Add
156 Persistent Clonal Plasma Cells in Patients with Lymphoplasmacytic Lymphoma (1259)
JD Sublett, MA Yared, RB Lorsbach - University of Arkansas for Medical Sciences, Little Rock, AR 		Add
157 Expression of Golgin-84 in Non-Hodgkin Lymphomas and Plasma Cell Myeloma (1289)
MJ You, CC Yin, LJ Medeiros, HR Bose, DM Dorfman - UT MD Anderson Cancer Center, Houston, TX; University of Texas at Austin, Austin, TX; Brigham and Women's Hospital, Boston, MA 		Add
158 The Prevalence of 7q32 Deletions in Small B-Cell Lymphomas (1195)
ME Law, A Dogan, A Feldman, PJ Kurtin, ED Remstein - Mayo Clinic, Rochester, MN 		Add
159 Novel Chemiluminescence Immunoassay for the Detection of Serum Thymidine Kinase Correlates Well with the Radioenzyme Method in Patients with Untreated Chronic Lymphocytic Leukemia (1185)
MR Johnson, H Fritsche, T Gornet, CE Bueso-Ramos - UT M.D. Anderson Cancer Center, Houston 		Add
160 Multiparametric Flow Cytometric Expression of CD38, but Not ZAP-70, Is Associated with Diffuse Infiltration Pattern and Extent of Bone Marrow Infiltration in B-Cell Chronic Lymphocytic Leukemia (1149)
W Cui, J Woodroof, ML Zucker, L Menninger, J Rachel, SC Mathur - VA Medical Center, Kansas City, MO; University of Kansas Medical Center, Kansas City, KS; Physicians Reference Laboratory, Overland Park, KS; Saint Luke's Regional Laboratories, Kansas City, MO 		Add
161 Monoclonal B-Cell Lymphocytosis: A Bone Marrow Study of an Indolent Form of Chronic Lymphocytic Leukemia (1173)
JL Herrick, TD Shanafelt, NE Kay, DL VanDyke, WG Morice, CA Hanson - Mayo Clinic, Rochester, MN 		Add
162 Prognostic Significance of Ki-67 in Mantle Cell Lymphoma Treated with Hyper-CVAD (1163)
M Garcia, JE Romaguera, KV Inamdar, GZ Rassidakis, LJ Medeiros - M.D. Anderson Cancer Ctr, Houston, TX 		Add
163 Correlation of cyclin D1 Transcript Levels, Transcript Type and Protein Expression with Proliferation and Histology among Mantle Cell Lymphoma (1251)
R Shakir, N Ngo, KN Naresh - Hammersmith Hospital & Imperial College, London, United Kingdom 		Add
164 Overexpression of Sphingosine-1-Phosphate Receptor 1 in Mantle Cell Lymphoma (1245)
Y Sadahira, H Nishimura, T Akiyama, I Irei, J Tsuchiyama, S Hamazaki - Kawasaki Medical School, Kurashiki, Okayama, Japan 		Add
165 Overexpression of cyclin D1 Is Rare in Aggressive B-Cell Non-Hodgkin Lymphomas Other Than Mantle Cell Lymphoma (1280)
TA Vela-Chávez, M Kremer, K Bink, F Fend, L Quintanilla-Martínez - Technical University Munich, Munich, Germany; GSF Research Center for Environment and Health, Oberschleissheim, Germany 		Add
166 Expression of the Intronic, Endothelial Cell-Related miR-126 in Human B-Cell Lymphomas (1264)
W Tam, H Allawi, S Agarwal, T Zhang, YF Liu, K Nie, T Rengifo, A Chadburn, DM Knowles - Weill Cornell Medical College, New York, NY; Third Wave Technologies, Madison, NY 		Add
167 Genomic Profile of Primary Effusion Lymphoma (1203)
SL Luan, N Johnson, E Boulanger, A Chadburn, E Cesarman, CM Bacon, H Liu, MQ Du - University of Cambridge, Cambridge, United Kingdom; Hôpital Saint Louis, Paris, France; Weill Medical College of Cornell University, New York 		Add
168 Extramedullary Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders: Clinical and Pathologic Features (1237)
B Richendollar, ED Hsi, JR Cook - Cleveland Clinic, Cleveland, OH 		Add
169 Tumor Infiltrating Cytotoxic T Cells Correlate with Favorable Outcome in Monomorphic B Cell Post Transplant Lymphoproliferative Disorder (1238)
B Richendollar, RE Tsao, T Jin, B Pohlman, ED Hsi - Cleveland Clinic, Cleveland, OH 		Add
170 Changes of Immunophenotype in B-NHL after Rituximab Treatment: Impact for Diagnostic Evaluation and Follow-Up (1124)
C Aumueller, C Meyer zum Bueschenfelde, I Koch, L Quintanilla-Martinez, F Fend, M Kremer - Technical University, Munich, Germany; GSF Research Center for Environment and Health, Neuherberg, Germany 		Add
171 C-C Chemokine Receptor 1 Is Expressed in Specific Subsets of B Cell Lymphomas (1122)
MW Anderson, S Zhao, IS Lossos, Y Natkunam - Stanford University School of Medicine, Stanford, CA; University of Miami, Miami, FL 		Add
172 Genomic Profiling Using Array-Based Comparative Genomic Hybridization in Chronic Lymphocytic Leukemia (1248)
R Sargent, R Luthra, J Bailey, P Tsang, A Sheffer-Wong, S Vacha, M Keating, L Abruzzo, D Jones - UT-MD Anderson Cancer Center, Houston; Agilent Technologies, Santa Clara 		Add
173 Marginal Zone Lymphomas with Extensive Plasmacytic Differentiation Are Tumors Composed of Clonal Plasmablasts (1223)
F Olobatuyi, R Naturale, HJ Meyerson - University Hospitals Case Medical Center, Cleveland, OH 		Add